24/7 Market News Snapshot 13 August, 2025 – X4 Pharmaceuticals, Inc. Common Stock (NASDAQ:XFOR)

August 13, 2025

DENVER, Colo., 13 August, 2025 (www.247marketnews.com) – (NASDAQ:XFOR) are discussed in this article.
X4 Pharmaceuticals, Inc. (XFOR) is experiencing a notable surge in trading activity, with shares reaching $3.225 in pre-market trading, reflecting a 25% increase from the previous close of $2.580. This robust trading volume of 13.27 million shares highlights an intensified market interest and positive sentiment regarding the company’s future prospects.

Adding to this momentum, X4 has successfully completed an upsized private placement, raising $85 million through the issuance of over 11 million shares of common stock and pre-funded warrants, surpassing the initial target of $60 million. This strategic financing was expanded to accommodate a key investor with established rights, signaling strong confidence in X4’s growth trajectory. The offering was led by Coastlands Capital, with participation from notable investors such as Empery Asset Management, Bain Capital Life Sciences, and New Enterprise Associates, along with other prominent life science stakeholders.

The proceeds from this placement will be directed towards advancing mavorixafor, focusing on obtaining additional approvals for chronic neutropenia and supporting the commercialization of WHIM syndrome treatments. Mavorixafor functions as an oral CXCR4 antagonist and is already marketed in the U.S. as XOLREMDI®, being a pivotal element of X4’s advancement strategy.

In accordance with SEC regulations, X4 will file a registration statement to facilitate the resale of the newly issued common stock and the associated pre-funded warrants. As the company positions itself for future developments, this financial influx is expected to enhance its clinical trials and outreach, reinforcing its commitment to pioneering therapeutic solutions for patients facing significant unmet medical needs in the area of rare immune diseases. X4 Pharmaceuticals is poised to be a pivotal player in this vital segment of healthcare.

Related news for (XFOR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.